Tandem Diabetes Care, Inc. (TNDM) earnings
TNDM earnings moved a median of +1.54% by the close. Quarterly and annual TNDM reports and results, each read against the price at its own news timestamp. Back to the TNDM overview →
30 measured TNDM earnings events.
Where these TNDM earnings landedvs 30 measured TNDM earnings reactions
| Middle 50% of TNDM earnings reactions | -1.71% to +6.35% |
|---|---|
| Median reaction (to close) | +1.54% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 TNDM earnings events with a measured close landed between -1.71% and +6.35%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026 | Press release | -1.74% | -0.96% | |
| Form 10-Q TANDEM DIABETES CARE For: Jun 30 | SEC filing · Form 10-Q | +9.89% | +30.27% | |
| Tandem Diabetes Care Announces Second Quarter 2026 Financial Results | Press release | +9.89% | +30.27% | |
| Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026 | Press release | +0.25% | -4.55% | |
| Form 10-Q TANDEM DIABETES CARE For: Mar 31 | SEC filing · Form 10-Q | -6.55% | -22.60% | |
| Tandem Diabetes Care Announces First Quarter 2026 Financial Results | Press release | -6.55% | -22.60% | |
| Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026 | Press release | -0.36% | +3.85% | |
| Form 10-K TANDEM DIABETES CARE For: Dec 31 | SEC filing · Form 10-K | -1.41% | +8.00% | |
| Form 10-Q TANDEM DIABETES CARE For: Sep 30 | SEC filing · Form 10-Q | -2.50% | +1.63% | |
| Tandem Diabetes Care Announces Third Quarter 2025 Financial Results | Press release | -2.50% | +1.63% | |
| Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025 | Press release | +0.91% | +11.36% | |
| Form 10-Q TANDEM DIABETES CARE For: Jun 30 | SEC filing · Form 10-Q | -0.43% | +10.77% | |
| Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance | Press release | -0.43% | +10.77% | |
| Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025 | Press release | +1.26% | -1.95% | |
| Form 10-Q TANDEM DIABETES CARE For: Mar 31 | SEC filing · Form 10-Q | +1.45% | +7.07% | |
| Tandem Diabetes Care Announces First Quarter 2025 Financial Results | Press release | +1.45% | +7.07% | |
| Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025 | Press release | -0.29% | -1.17% | |
| Form 10-K TANDEM DIABETES CARE For: Dec 31 | SEC filing · Form 10-K | -2.01% | -10.05% | |
| Form 10-Q TANDEM DIABETES CARE For: Sep 30 | SEC filing · Form 10-Q | -3.25% | -1.71% | |
| Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance | Press release | -3.25% | -1.71% | |
| Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024 | Press release | +0.51% | -1.44% | |
| Form 10-Q TANDEM DIABETES CARE For: Jun 30 | SEC filing · Form 10-Q | -0.39% | +1.02% | |
| Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance | Press release | -0.39% | +1.02% | |
| Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024 | Press release | -0.29% | +1.45% | |
| Form 10-Q TANDEM DIABETES CARE For: Mar 31 | SEC filing · Form 10-Q | +4.17% | +4.19% | |
| Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance | Press release | +4.17% | +4.19% | |
| Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024 | Press release | +0.36% | +3.72% | |
| Form 10-K TANDEM DIABETES CARE For: Dec 31 | SEC filing · Form 10-K | +6.45% | +2.04% | |
| Form 10-Q TANDEM DIABETES CARE For: Sep 30 | SEC filing · Form 10-Q | +1.56% | -3.49% | |
| Tandem Diabetes Care Announces Third Quarter 2023 Financial Results | Press release | +1.56% | -3.49% |
Keep exploring
More TNDM: analyst actions → · SEC filings → · TNDM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| KemPharm, Inc. (KMPH) | 901 | -0.21% | 40% |
| Nektar Therapeutics (NKTR) | 898 | +0.07% | 53% |
| Flexion Therapeutics, Inc. (FLXN) | 891 | 0.00% | 48% |
| Paratek Pharmaceuticals, Inc. (PRTK) | 891 | -0.18% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.